Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604

Sarah Caspersen, Christian Mortensen, Lene Riis, Tine Jess, Flemming Bendtsen, Sarah Caspersen, Christian Mortensen, Lene Riis, Tine Jess, Flemming Bendtsen

Abstract

Udgivelsesdato: 2009-Nov
Original languageEnglish
JournalClinical Gastroenterology and Hepatology
Volume7
Issue number11
Pages (from-to)1257
ISSN1542-3565
DOIs
Publication statusPublished - 2009

Cite this